Targeting Kinases For Drug Discovery

Targeting Kinases for Drug Discovery

Drug Discovery World

Targeting Kinases for Drug Discovery (Bonus Webinar Episode)

Drug Discovery World

Recent Trends in Kinase Drug Discovery

Eurofins Discovery

Dsicovery of Selective Inhibitors for 123 Kinases:Kinase Inhibitor Discovery Platform

Axcelead Drug Discovery Partners, Inc.

Targeting the human kinome: cancer drug discovery

The Royal Society

Behnam Nabet - Dana-Farber Targeted Degradation Webinar Series

Dana-Farber TPD

5.6 Drug targets - too many kinases

Nathanael Gray - Dana-Farber Targeted Protein Degradation Webinar Series

Dana-Farber TPD

Katherine Donovan - Dana-Farber Targeted Degradation Webinar Series

Dana-Farber TPD

Targeted Protein Degradation to Advance Oncology Drug Discovery

Cell Signaling Technology, Inc.

Use of VEGF-Targeted Tyrosine Kinase Inhibitors

Trending Targets: Monitoring Targets in Drug Discovery through the Years

BioSolveITTutorials

Lock and Key with SignalChem Biotech: Drug Discovery in Action

Sino Biological, Inc.

Kilian Huber: Targeting drug discovery

Nuffield Department of Medicine

Biophysics in kinase drug discovery: FBS to PROTAC® ternary complex characterisation

Eurofins Discovery

Targeting Proteomics to Decipher Biology for the Drug Development Pipeline

Cell Signaling Technology, Inc.

Jim Wells and Michelle Arkin(UCSF) Part 1: Introduction to Drug Discovery

Science Communication Lab

Professor Sir Philip Cohen: “Protein Kinases, the Major Drug Targets of the 21st Century” WCC 2014

Aalto University

Advances and Challenges in Targeting Kinases in Cancer Therapeutics

Advances and Challenges in Targeting Kinases in Cancer Therapeutics